These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10493496)

  • 61. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
    Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
    Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps.
    Gawrońska-Szklarz B; Lubiński J; Kladny J; Kurzawski G; Bielicki D; Wójcicki M; Sych Z; Musial HD
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):321-5. PubMed ID: 10445390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Southwestern internal medicine conference: hereditary predisposition to colorectal cancer: new insights.
    Smith RG
    Am J Med Sci; 1994 Nov; 308(5):295-308. PubMed ID: 7977449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer.
    Bright-Thomas RM; Hargest R
    Eur J Surg Oncol; 2003 Mar; 29(2):107-17. PubMed ID: 12633551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. beta-Catenin and ras oncogenes detect most human colorectal cancer.
    Zhang B; Ougolkov A; Yamashita K; Takahashi Y; Mai M; Minamoto T
    Clin Cancer Res; 2003 Aug; 9(8):3073-9. PubMed ID: 12912959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
    Rowan AJ; Lamlum H; Ilyas M; Wheeler J; Straub J; Papadopoulou A; Bicknell D; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3352-7. PubMed ID: 10737795
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
    Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
    Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The gatekeeper has many keys: dissecting the function of the APC gene.
    Bresalier RS
    Gastroenterology; 1997 Dec; 113(6):2009-10. PubMed ID: 9394744
    [No Abstract]   [Full Text] [Related]  

  • 69. Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity.
    Smits R; Hofland N; Edelmann W; Geugien M; Jagmohan-Changur S; Albuquerque C; Breukel C; Kucherlapati R; Kielman MF; Fodde R
    Genes Chromosomes Cancer; 2000 Nov; 29(3):229-39. PubMed ID: 10992298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis.
    Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Yabu M; Himeno S; Imanishi K; Ohsawa M; Wada H; Tominaga S; Shimano T; Kobayashi T; Nakamura Y
    Cancer Lett; 2000 Oct; 159(1):73-8. PubMed ID: 10974408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.
    Aust DE; Terdiman JP; Willenbucher RF; Chang CG; Molinaro-Clark A; Baretton GB; Loehrs U; Waldman FM
    Cancer; 2002 Mar; 94(5):1421-7. PubMed ID: 11920497
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Genetic testing and gene--based testing for colorectal cancer].
    Yabana T; Goto A; Arimura Y; Shinomura Y; Imai K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():217-22. PubMed ID: 16416797
    [No Abstract]   [Full Text] [Related]  

  • 74. [Pathogenetic germ-line mutation in patients with hereditary nonpolyposis colorectal carcinoma (HNPCC)].
    Trojan J; Raedle J; Zeuzem S
    Z Gastroenterol; 1999 Apr; 37(4):321-4. PubMed ID: 10378370
    [No Abstract]   [Full Text] [Related]  

  • 75. Somatic mutations of APC gene in carcinomas from hereditary non-polyposis colorectal cancer patients.
    Huang J; Zheng S; Jin SH; Zhang SZ
    World J Gastroenterol; 2004 Mar; 10(6):834-6. PubMed ID: 15040027
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The genetics of hereditary non-polyposis colorectal cancer.
    Gruber SB; Kohlmann W
    J Natl Compr Canc Netw; 2003 Jan; 1(1):137-44. PubMed ID: 19764157
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advances in the genetics and molecular biology of colorectal tumors.
    Thomas G
    Curr Opin Oncol; 1994 Jul; 6(4):406-12. PubMed ID: 7803543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Establishment and characterization of 12 human colorectal-carcinoma cell lines.
    Oh JH; Ku JL; Yoon KA; Kwon HJ; Kim WH; Park HS; Yeo KS; Song SY; Chung JK; Park JG
    Int J Cancer; 1999 Jun; 81(6):902-10. PubMed ID: 10362137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer.
    den Bakker MA; Seynaeve C; Kliffen M; Dinjens WN
    Histopathology; 2003 Sep; 43(3):297-9. PubMed ID: 12940783
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro transcription/translation analysis for the identification of translation-terminating mutations.
    Luce MC; Binnie CG; Kam-Morgan LN; Cayouette MC
    Methods Mol Biol; 1998; 92():127-44. PubMed ID: 9664509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.